Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity
Journal of Natural Products · 2025
DOI: 10.1021/acs.jnatprod.5c00887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2025. Verfasst von Marta Alberti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via G. Bovio 6, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Oxidoreductases Acting on CH-CH Group Donors, Antiviral Agents, Pyrones, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nvidia, Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Human dihydroorotate dehydrogenase (hDHODH), catalyzing the rate-limiting step of the pyrimidine biosynthesis pathway (PBP), is a drug target extensively investigated for various diseases including cancer, autoimmune disorders, and viral infections. We present evidence that the heterodimeric phloroglucinylpyrone arzanol potently inhibits hDHODH by competing with ubiquinone for binding to the lipophilic patch (LP) of the enzyme. Co-crystallization experiments on the enzyme-arzanol complex provided further insights into the binding pocket of hDHODH, revealing detailed features that could inspire the design of innovative inhibitors. The cellular translation of these enzymatic and biochemical data was validated in antiviral assays on SARS-CoV-2 infected cells. Taken together, these results exemplify the potential of natural products to explore novel areas of the protein druggable space and provide information relevant to multiple critical areas of drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Piemonte Orientale, Via G. Bovio 6, 28100 Novara, Italy.
- Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Department of Life and Environmental Sciences, University of Cagliari, Via Sant'Ignazio da Laconi 13, 09123 Cagliari, Italy.
- Department of Sciences and Drug Technology, University of Torino, Via P. Giuria 9, 10125 Torino, Italy.
ORCID-Profile: Marta Alberti, Giovanni Battista Appendino, Marco L Lolli, Alberto Massarotti, Federica Pollastro, Riccardo Miggiano
Förderung
- Nvidia
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Alberti, M., Tamburello, M., Salamone, S., Gallinella, G., Sanna, C., Appendino, G. B., Lolli, M. L., Massarotti, A., Pollastro, F., & Miggiano, R. (2025). Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.5c00887
Vancouver
Alberti M, Tamburello M, Salamone S, Gallinella G, Sanna C, Appendino GB, et al. Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity. Journal of Natural Products. 2025. doi:10.1021/acs.jnatprod.5c00887
BibTeX
@article{Alberti2025,
author = {Alberti, Marta and Tamburello, Martina and Salamone, Stefano and Gallinella, Giorgio and Sanna, Cinzia and Appendino, Giovanni Battista and Lolli, Marco L and Massarotti, Alberto and Pollastro, Federica and Miggiano, Riccardo},
title = {Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity},
journal = {Journal of Natural Products},
year = {2025},
doi = {10.1021/acs.jnatprod.5c00887}
}
EUVIMED